- |||||||||| Vascepa (icosapent ethyl) / Amarin
Vascepa!!!!! (Twitter) - Jun 28, 2019
- |||||||||| Vascepa (icosapent ethyl) / Amarin
Clinical, Journal: Clinical trials of eicosapentaenoic acid (EPA) prescription products for the treatment of hypertriglyceridemia. (Pubmed Central) - Jun 25, 2019 However, as the fibrates reduce the triglyceride levels by similar amounts to the EPA ethyl esters, while increasing the levels of HDL cholesterol, they are an alternative to EPA ethyl esters in combination with statins. As the proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors reduce triglycerides to a similar extent to the EPA ethyl ester, while reducing LDL cholesterol levels to a greater extent than the statins, they should be considered as an alternative to the statin/EPA ethyl ester combination.
|